Skip to main content

InvestorNewsBreaks – Brain Scientific Inc. (BRSFD), Life After PTSD Partner to Evaluate, Expand PTSD Treatment Solutions

Brain Scientific (OTCQB: BRSF, BRSFD), a Florida-based applied science technology company, announced plans to collaborate closely with Life After PTSD, the developers of a leading PTSD treatment protocol, in the treatment of post-traumatic stress disorder (“PTSD”). The two companies plan to evaluate the potential for incorporating BRSF’s NeuroCap(TM) and NeuroEEG(TM) system with Life After PTSD’s groundbreaking Managing Emotional States Effectively(C) (“MESE”) protocol. According to the announcement, Brain Scientific’s easy-to-use, quick-to-set-up, integrated EEG solution has potential to be an important component in MESE’s PTSD protocol, which 80 practitioners have used successfully on more than 1,500 patients. The partnership will facilitate an expansion of the protocol to thousands of practitioners across the United States. The MESE approach enables clients to revisit distressing, traumatic memories from a safe distance and, with the help of a trained clinician or paraprofessional, allow an alternate experience that is significantly less triggering and that provides an opportunity for the client to move on. “It’s important to us to create products that are not only groundbreaking but also making an important and positive difference in our world,” said Brain Scientific CEO Hassan Kotob in the press release. “We’re delighted that Life After PTSD has selected Brain Scientific’s integrated system to help them expand their PTSD treatment protocol and help those impacted by PTSD live better lives.”

To view the full press release, visit

About Brain Scientific Inc.

Brain Scientific is an applied sciences technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of medical and OEM devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap(TM) and NeuroEEG(TM) are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultraefficient compact precision motors that will drive the next generation of OEM devices. To learn more about the company, visit

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.